BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158-S168. [PMID: 15602165 DOI: 10.1097/00004836-200411003-00008] [Cited by in Crossref: 362] [Cited by in F6Publishing: 356] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 An P, Winkler C, Guan L, O’Brien SJ, Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis. 2011;203:943-947. [PMID: 21402545 DOI: 10.1093/infdis/jiq154] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
2 Lu JJ, Liu K, Ma YJ, Wang J, Chen EQ, Tang H. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil. J Viral Hepat. 2013;20 Suppl 1:40-45. [PMID: 23458523 DOI: 10.1111/jvh.12062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
3 Jin BX, Zhang YH, Jin WJ, Sun XY, Qiao GF, Wei YY, Sun LB, Zhang WH, Li N. MicroRNA panels as disease biomarkers distinguishing hepatitis B virus infection caused hepatitis and liver cirrhosis. Sci Rep. 2015;5:15026. [PMID: 26456479 DOI: 10.1038/srep15026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
4 Sun Y, Li L, Li J, Li Z. Inhibition of hepatitis B virus replication by Rheum palmatum L. ethanol extract in a stable HBV-producing cell line. Virol Sin 2007;22:14-20. [DOI: 10.1007/s12250-007-0056-6] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
5 Yang H, Hung H, Lee M, Liu J, Jen C, Su J, Wang L, Lu S, You S, Iloeje UH, Chen C. Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2012;10:527-534.e2. [DOI: 10.1016/j.cgh.2011.12.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
6 Erhardt A, Göbel T, Ludwig A, Lau GK, Marcellin P, van Bömmel F, Heinzel-Pleines U, Adams O, Häussinger D. Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H. J Med Virol. 2009;81:1716-1720. [PMID: 19697400 DOI: 10.1002/jmv.21588] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
7 Liu M, Wang Y, Zhao J, Zheng S, Ungvari GS, Ng CH, Duan ZP, Xiang Y. The Psychometric Properties of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) in Patients with HBV-Related Liver Disease. Shanghai Arch Psychiatry 2017;29:15-20. [PMID: 28769541 DOI: 10.11919/j.issn.1002-0829.216076] [Reference Citation Analysis]
8 Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007;109:2100-8. [PMID: 17385214 DOI: 10.1002/cncr.22642] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
9 Song IH, Kim SM, Choo YK. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. World J Gastroenterol 2013; 19(47): 8867-8872 [PMID: 24379609 DOI: 10.3748/wjg.v19.i47.8867] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Yang JH, Zhang H, Chen XB, Chen G, Wang X. Relationship between hepatocellular carcinoma and hepatitis B virus genotype with spontaneous YMDD mutations. World J Gastroenterol 2013; 19(24): 3861-3865 [PMID: 23840126 DOI: 10.3748/wjg.v19.i24.3861] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
11 Nguyen K, Van Nguyen T, Shen D, Xia V, Tran D, Banh K, Ruan V, Hu K. Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans via Serial Community Serologic Testing. J Immigrant Minority Health 2015;17:13-20. [DOI: 10.1007/s10903-013-9975-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Do SH, Yamada H, Fujimoto M, Ohisa M, Matsuo J, Akita T, Katayama K, Van Nguyen N, Miyakawa Y, Tanaka J. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam. Hepatol Res. 2015;45:259-268. [PMID: 24799322 DOI: 10.1111/hepr.12350] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
13 Abu Zeid WM, Ramadan DI, Shemis MA. Prevalence of mutations within major hydrophilic region of hepatitis B virus and their correlation with genotypes among chronically infected patients in Egypt. Arab J Gastroenterol 2016;17:34-40. [PMID: 27055927 DOI: 10.1016/j.ajg.2016.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Blondeel K, Say L, Chou D, Toskin I, Khosla R, Scolaro E, Temmerman M. Evidence and knowledge gaps on the disease burden in sexual and gender minorities: a review of systematic reviews. Int J Equity Health 2016;15:16. [PMID: 26800682 DOI: 10.1186/s12939-016-0304-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
15 Akbal E, Koçak E, Köklü S, Ergül B, Akyürek Ö, Yılmaz FM. Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B. Viral Immunol 2017;30:278-82. [PMID: 28414577 DOI: 10.1089/vim.2016.0131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
16 de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol. 2009;70:183-194. [PMID: 18805702 DOI: 10.1016/j.critrevonc.2008.07.021] [Cited by in Crossref: 154] [Cited by in F6Publishing: 126] [Article Influence: 11.0] [Reference Citation Analysis]
17 Coppola RC, Meloni A, Campagna M. Impact of universal vaccination against hepatitis B: the italian model. Hepat Mon 2012;12:417-9. [PMID: 23008720 DOI: 10.5812/hepatmon.6396] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Dasse KD, Lander MJ, Novelli PM. Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma. J Adv Pract Oncol 2016;7:764-78. [PMID: 29670812 DOI: 10.6004/jadpro.2016.7.7.8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Pourkarim MR, Ranst MV. Guidelines for the Detection of a Common Source of Hepatitis B Virus Infections. Hepat Mon 2011;11:783-5. [DOI: 10.5812/kowsar.1735143x.1009] [Reference Citation Analysis]
20 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
21 Jackson V, Ferguson W, Kelleher TB, Lawless M, Eogan M, Nusgen U, Coughlan S, Connell J, Lambert JS. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis 2015;34:619-23. [PMID: 25381607 DOI: 10.1007/s10096-014-2270-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
22 Hsu L, Bowlus CL, Stewart SL, Nguyen TT, Dang J, Chan B, Chen MS Jr. Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci 2013;58:807-14. [PMID: 23073671 DOI: 10.1007/s10620-012-2396-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
23 Ling Q, Xu X, Wei Q, Liu X, Guo H, Zhuang L, Chen J, Xia Q, Xie H, Wu J. Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure. PLoS One. 2012;7:e30322. [PMID: 22291934 DOI: 10.1371/journal.pone.0030322] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
24 Ziraba AK, Bwogi J, Namale A, Wainaina CW, Mayanja-Kizza H. Sero-prevalence and risk factors for hepatitis B virus infection among health care workers in a tertiary hospital in Uganda. BMC Infect Dis. 2010;10:191. [PMID: 20587047 DOI: 10.1186/1471-2334-10-191] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 5.0] [Reference Citation Analysis]
25 Lv N, Chu XD, Sun YH, Zhao SY, Li PL, Chen X. Analysis on the outcomes of hepatitis B virus perinatal vertical transmission: nested case-control study. Eur J Gastroenterol Hepatol 2014;26:1286-91. [PMID: 25171026 DOI: 10.1097/MEG.0000000000000189] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Islami F, Dikshit R, Mallath MK, Jemal A. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India. Cancer Epidemiol 2016;40:79-86. [PMID: 26683034 DOI: 10.1016/j.canep.2015.11.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Dang JH, Chen MS Jr. Increasing Hepatitis B Testing and Linkage to Care of Foreign-Born Asians, Sacramento, California, 2012-2013. Public Health Rep 2016;131 Suppl 2:119-24. [PMID: 27168671 DOI: 10.1177/00333549161310S218] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
28 Yizengaw E, Getahun T, Geta M, Mulu W, Ashagrie M, Hailu D, Tedila S. Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of North-west Ethiopia. BMC Res Notes 2018;11:437. [PMID: 29970163 DOI: 10.1186/s13104-018-3538-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
29 Liu CJ, Chen PJ, Chen DS. Dual chronic hepatitis B virus and hepatitis C virus infection. Hepatol Int. 2009;3:517-525. [PMID: 19669238 DOI: 10.1007/s12072-009-9147-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
30 Zhang Q, Chen X, Zang Y, Zhang L, Chen H, Wang L, Niu Y, Ren X, Shen Z, Shang L. The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis. PLoS One. 2012;7:e50919. [PMID: 23236406 DOI: 10.1371/journal.pone.0050919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Hu HH, Liu J, Lin YL, Luo WS, Chu YJ, Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, You SL, Yang HI, Chen CJ;  REVEAL-HBV Study Group. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. Gut. 2016;65:1514-1521. [PMID: 26642861 DOI: 10.1136/gutjnl-2015-310686] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
32 Alvarado-Esquivel C, Sablon E, Conde-González CJ, Juárez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S. Molecular analysis of hepatitis B virus isolates in Mexico: Predominant circulation of hepatitis B virus genotype H. World J Gastroenterol 2006; 12(40): 6540-6545 [PMID: 17072988 DOI: 10.3748/wjg.v12.i40.6540] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
33 Ndifontiayong AN, Ali IM, Sokoudjou JB, Ndimumeh JM, Tume CB. The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon. Trop Med Infect Dis 2021;6:150. [PMID: 34449737 DOI: 10.3390/tropicalmed6030150] [Reference Citation Analysis]
34 Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathologie Biologie 2010;58:273-7. [DOI: 10.1016/j.patbio.2010.01.005] [Cited by in Crossref: 168] [Cited by in F6Publishing: 167] [Article Influence: 14.0] [Reference Citation Analysis]
35 Zou ZQ, Zhang S, Lin Q, Qu RL, Li YF, Zhang FH, Xu AL. Immune response- and viral control-related pathways in the progression of chronic hepatitis B. Microb Pathog 2017;105:100-5. [PMID: 28189731 DOI: 10.1016/j.micpath.2017.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
36 Idris BI, Brosa M, Richardus JH, Esteban R, Schalm SW, Buti M. Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain: . European Journal of Gastroenterology & Hepatology 2008;20:320-6. [DOI: 10.1097/meg.0b013e3282f340c8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
37 Sundquist K, Sundquist J, Ji J. Risk of hepatocellular carcinoma and cancers at other sites among patients diagnosed with chronic hepatitis B virus infection in Sweden. J Med Virol. 2014;86:18-22. [PMID: 24038002 DOI: 10.1002/jmv.23754] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
38 Lee H, Yang JH, Cho MO, Fawcett J. Complexity and uncertainty of living with an invisible virus of hepatitis B in Korea. J Cancer Educ 2010;25:337-42. [PMID: 20186522 DOI: 10.1007/s13187-010-0047-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
39 Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang XS, Zhang P, Zhao JF. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut. 2008;57:1713-1720. [PMID: 18755887 DOI: 10.1136/gut.2008.157149] [Cited by in Crossref: 81] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
40 Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034-1040. [PMID: 17654490 DOI: 10.1002/hep.21784] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 10.6] [Reference Citation Analysis]
41 Alam MM, Zaidi SZ, Shaukat S, Sharif S, Angez M, Naeem A, Saleha S, Butt JA, Malik SA. Common genotypes of Hepatitis B virus prevalent in injecting drug abusers (addicts) of North West Frontier Province of Pakistan. Virol J 2007;4:63. [PMID: 17597548 DOI: 10.1186/1743-422X-4-63] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
42 Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol. 2006;101:1797-1803. [PMID: 16817842 DOI: 10.1111/j.1572-0241.2006.00647.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 159] [Article Influence: 10.8] [Reference Citation Analysis]
43 Sebastiani G, Gkouvatsos K, Plebani M. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. Clin Chem Lab Med. 2011;49:13-32. [PMID: 20961196 DOI: 10.1515/cclm.2011.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Lee HO, Lee OJ, Kim S, Hontz I, Warner A. Differences in knowledge of hepatitis B among korean immigrants in two cities in the rocky mountain region. Asian Nurs Res (Korean Soc Nurs Sci) 2007;1:165-75. [PMID: 25030884 DOI: 10.1016/S1976-1317(08)60019-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
45 Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes 2014;7:833. [PMID: 25424315 DOI: 10.1186/1756-0500-7-833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
46 Woller N, Kühnel F. Virus infection, inflammation and prevention of cancer. Recent Results Cancer Res. 2014;193:33-58. [PMID: 24008292 DOI: 10.1007/978-3-642-38965-8_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
47 Kwon E, Cho JH, Jang HM, Kim YS, Kang SW, Yang CW, Kim NH, Kim HJ, Park JM, Lee JE. Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study. PLoS One. 2015;10:e0135476. [PMID: 26263373 DOI: 10.1371/journal.pone.0135476] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
48 Jamil KM, Khakoo SI. KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol 2011;2011:298348. [PMID: 21629750 DOI: 10.1155/2011/298348] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.5] [Reference Citation Analysis]
49 Sun S, Meng S, Zhang R, Zhang K, Wang L, Li J. Development of a new duplex real-time polymerase chain reaction assay for hepatitis B viral DNA detection. Virol J. 2011;8:227. [PMID: 21569595 DOI: 10.1186/1743-422x-8-227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
50 Dun-Dery F, Adokiya MN, Walana W, Yirkyio E, Ziem JB. Assessing the knowledge of expectant mothers on mother-to-child transmission of viral hepatitis B in Upper West region of Ghana. BMC Infect Dis 2017;17:416. [PMID: 28606057 DOI: 10.1186/s12879-017-2490-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kardam P, Mehendiratta M, Rehani S, Kumra M. Seroprevalence and vaccination status of hepatitis B amongst dental health-care workers in North India. Indian J Gastroenterol 2014;33:190-1. [PMID: 23996799 DOI: 10.1007/s12664-013-0370-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Gupta K, Cooper C. A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases. Drugs R D. 2008;9:137-145. [PMID: 18457466 DOI: 10.2165/00126839-200809030-00001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
53 Panassié L, Borentain P, Nafati C, Bernardin G, Doudier B, Thibault V, Gerolami R, Colson P. Fatal fulminant primary hepatitis B virus infections with G1896A precore viral mutants in southeastern France. Clin Res Hepatol Gastroenterol 2012;36:e1-8. [PMID: 22037043 DOI: 10.1016/j.clinre.2011.09.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
54 Hur K, Wong M, Lee J, Lee J, Juon HS. Hepatitis B infection in the Asian and Latino communities of Alameda County, California. J Community Health 2012;37:1119-26. [PMID: 22362166 DOI: 10.1007/s10900-012-9553-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
55 Chang ET, Lin SY, Sue E, Bergin M, Su J, So SK. Building partnerships with traditional chinese medicine practitioners to increase hepatitis B awareness and prevention. J Altern Complement Med 2007;13:1125-7. [PMID: 18166125 DOI: 10.1089/acm.2007.0655] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
56 Billioud G, Kruse RL, Carrillo M, Whitten-Bauer C, Gao D, Kim A, Chen L, McCaleb ML, Crosby JR, Hamatake R, Hong Z, Garaigorta U, Swayze E, Bissig KD, Wieland S. In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides. J Hepatol. 2016;64:781-789. [PMID: 26658683 DOI: 10.1016/j.jhep.2015.11.032] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
57 Jarcuska P, Janicko M, Veselíny E, Jarcuska P, Skladaný L. Circulating markers of liver fibrosis progression. Clin Chim Acta. 2010;411:1009-1017. [PMID: 20399764 DOI: 10.1016/j.cca.2010.04.009] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.7] [Reference Citation Analysis]
58 Yang J, Chen X, Zhang H, Chen G. HBV genotype C strains with spontaneous YMDD mutations may be a risk factor for hepatocellular carcinoma. J Med Virol. 2014;86:913-917. [PMID: 24615989 DOI: 10.1002/jmv.23895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
59 Wang D, Xie W, Chen T, Dong C, Zhao C, Tan H, Tian H, Xie Q. Evaluation of the Potential Risk of Hepatitis B Virus Transmission in Skin Allografting. Transplantation Proceedings 2015;47:1993-7. [DOI: 10.1016/j.transproceed.2015.03.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
60 Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation. World J Gastroenterol 2016; 22(43): 9571-9585 [PMID: 27920478 DOI: 10.3748/wjg.v22.i43.9571] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
61 Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011;21:401-416. [PMID: 22041528 DOI: 10.2188/jea.je20100190.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Kim LH, Nguyen VG, Trinh HN, Li J, Zhang JQ, Nguyen MH. Low Treatment Rates in Patients Meeting Guideline Criteria in Diverse Practice Settings. Dig Dis Sci 2014;59:2091-9. [DOI: 10.1007/s10620-014-3283-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
63 Shang JW, Yan XL, Zhang H, Su SB. Expression and significance of urinary microRNA in patients with chronic hepatitis B. Medicine (Baltimore). 2019;98:e17143. [PMID: 31517857 DOI: 10.1097/md.0000000000017143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
64 Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529-538. [PMID: 16879891 DOI: 10.1016/j.jhep.2006.05.013] [Cited by in Crossref: 1610] [Cited by in F6Publishing: 1598] [Article Influence: 100.6] [Reference Citation Analysis]
65 Hiotis SP, Rahbari NN, Villanueva GA, Klegar E, Luan W, Wang Q, Yee HT. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma. BMC Gastroenterol. 2012;12:64. [PMID: 22681852 DOI: 10.1186/1471-230x-12-64] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
66 Mele A, Tosti ME, Mariano A, Pizzuti R, Ferro A, Borrini B, Zotti C, Lopalco P, Curtale F, Balocchini E. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis. 2008;46:868-875. [PMID: 18269332 DOI: 10.1086/528687] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
67 Lin C, Ding H, Lin C, Chen C, Sun S, Kao C. Impact of age on FDG uptake in the liver on PET scan. Clinical Imaging 2010;34:348-50. [DOI: 10.1016/j.clinimag.2009.11.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
68 Lesmana LA, Leung NW, Mahachai V, Phiet PH, Suh DJ, Yao G, Zhuang H. Hepatitis B: overview of the burden of disease in the Asia-Pacific region. Liver International 2006;26:3-10. [DOI: 10.1111/j.1478-3231.2006.01370.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
69 Liu H, Han T, Tian J, Zhu ZY, Liu Y, Li Y, Xiao SX, Li Y, Feng YY. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Hepatol Res. 2012;42:171-180. [PMID: 22103276 DOI: 10.1111/j.1872-034x.2011.00911.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
70 Gonzalez SA, Keeffe EB. Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance. Int J Clin Pract 2012;66:7-10. [PMID: 22171899 DOI: 10.1111/j.1742-1241.2011.02808.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
71 Han ZG, Qie ZH, Qiao WZ. HBsAg spontaneous seroclearance in a cohort of HBeAg-seronegative patients with chronic hepatitis B virus infection. J Med Virol. 2016;88:79-85. [PMID: 26111498 DOI: 10.1002/jmv.24311] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
72 Zhao J, Fan YC, Sun FK, Zhao ZH, Wang LY, Hu LH, Yin YP, Li T, Gao S, Wang K. Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection. J Interferon Cytokine Res 2013;33:405-14. [PMID: 23663046 DOI: 10.1089/jir.2012.0153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
73 Zhao J, Liu M, Ungvari GS, Ng CH, Chow IHI, Wang T, Chen Y, Duan Z, Xiang YT, Zheng SJ. Prevalence and clinical correlates of insomnia symptoms and their association with quality of life in Chinese patients with HBV-related liver disease. PeerJ 2021;9:e10956. [PMID: 33717693 DOI: 10.7717/peerj.10956] [Reference Citation Analysis]
74 Zetterström R. Nobel Prize to Baruch Blumberg for the discovery of the aetiology of hepatitis B. Acta Paediatr 2008;97:384-7. [PMID: 18298788 DOI: 10.1111/j.1651-2227.2008.00669.x] [Reference Citation Analysis]
75 Velan B, Yadgar Y. On the implications of desexualizing vaccines against sexually transmitted diseases: health policy challenges in a multicultural society. Isr J Health Policy Res 2017;6:30. [PMID: 28666469 DOI: 10.1186/s13584-017-0153-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
76 Matos MA, Reis NRS, Kozlowski AG, Teles SA, Motta-castro ARC, Mello FC, Gomes SA, Martins RM. Epidemiological study of hepatitis A, B and C in the largest Afro-Brazilian isolated community. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009;103:899-905. [DOI: 10.1016/j.trstmh.2009.01.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
77 Al Romaihi HE, Ganesan N, Farag EA, Smatti MK, Nasrallah GK, Himatt SM, Derbala MF, Alshamali M, Mahadoon LK, Khogali HS, Sallam M, Al Thani AA, Al Thani M, Al Kaabi S, Yassine HM. Demographics and Epidemiology of Hepatitis B in the State of Qatar: A Five-Year Surveillance-Based Incidence Study. Pathogens 2019;8:E68. [PMID: 31117254 DOI: 10.3390/pathogens8020068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
78 Williams JR, Manfredi P, Melegaro A. The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B. BMC Med 2018;16:118. [PMID: 30041645 DOI: 10.1186/s12916-018-1100-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
79 Sakai A, Noguchi E, Fukushima T, Tagawa M, Iwabuchi A, Kita M, Kakisaka K, Miyasaka A, Takikawa Y, Sumazaki R. Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response. Vaccine. 2017;35:703-710. [PMID: 28043736 DOI: 10.1016/j.vaccine.2016.08.068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
80 Chen J, Wang W, Li X, Xu J. A meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population. BMC Gastroenterol 2015;15:58. [PMID: 25962810 DOI: 10.1186/s12876-015-0286-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
81 Guriev V, Spinu C, Sajen O, Spinu I, Popovici S. Viral hepatitis B, C and HIV coinfection: Evaluation of some immunological and epidemiological aspects. HIV & AIDS Review 2014;13:46-9. [DOI: 10.1016/j.hivar.2014.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Atkinson PM, Graham AJ. Issues of scale and uncertainty in the global remote sensing of disease. Adv Parasitol 2006;62:79-118. [PMID: 16647968 DOI: 10.1016/S0065-308X(05)62003-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
83 Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas® TaqScreen MPX test in seroconverting donors. Journal of Clinical Virology 2007;39:282-7. [DOI: 10.1016/j.jcv.2007.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
84 Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. Journal of Hepatology 2012;57:885-96. [DOI: 10.1016/j.jhep.2012.03.036] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
85 Lee H, Baik SY. Health disparities or data disparities: sampling issues in hepatitis B Virus infection among Asian American Pacific Islander studies. Appl Nurs Res 2011;24:e9-e15. [PMID: 20974087 DOI: 10.1016/j.apnr.2009.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
86 Ajana F. L'hépatite virale B, encore et toujours d'actualité. Archives de Pédiatrie 2006;13:1269-74. [DOI: 10.1016/j.arcped.2006.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 Abdellatif H. Circulating CD34+ hematopoietic stem/progenitor cells paralleled with level of viremia in patients chronically infected with hepatitis B virus. Regen Med Res 2018;6:1. [PMID: 29461203 DOI: 10.1051/rmr/170005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Xie W, Shi GF, Zhang HF, Zhao GM, Yu ZJ, Lang ZW, Zhao H, Yan J, Cheng J. A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatol Int. 2012;6:441-448. [PMID: 21773778 DOI: 10.1007/s12072-011-9294-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
89 Shuler CM, Fiore AE, Neeman R, Bell BP, Kuhnert W, Watkins S, Kilgour K, Arnold KE. Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents -- benefit of universal infant hepatitis B vaccination. Vaccine 2009;27:5942-7. [PMID: 19679217 DOI: 10.1016/j.vaccine.2009.07.087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
90 Che YH, Chongsuvivatwong V, Li L, Sriplung H, Wang YY, You J, Ma SJ, Yan Y, Zhang RY, Shen T, Chen HM, Rao SF, Zhang XL. Financial burden on the families of patients with hepatitis B virus-related liver diseases and the role of public health insurance in Yunnan province of China. Public Health 2016;130:13-20. [PMID: 25931438 DOI: 10.1016/j.puhe.2015.03.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
91 Zou Z, Li B, Xu D, Zhang Z, Zhao JM, Zhou G, Sun Y, Huang L, Fu J, Yang Y, Jin L, Zhang W, Zhao J, Sun Y, Xin S, Wang FS. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol. 2009;43:182-190. [PMID: 18633332 DOI: 10.1097/mcg.0b013e3181624464] [Cited by in Crossref: 73] [Cited by in F6Publishing: 35] [Article Influence: 5.6] [Reference Citation Analysis]
92 Wan Z, You S, Rong Y, Zhu B, Zhang A, Zang H, Xiao L, Xie G, Xin S. CD34+ Hematopoietic Stem Cells Mobilization, Paralleled with Multiple Cytokines Elevated in Patients with HBV-Related Acute-on-Chronic Liver Failure. Dig Dis Sci 2013;58:448-57. [DOI: 10.1007/s10620-012-2458-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
93 Vergara Gómez M, Miquel Planas M, Gil Prades M, Dalmau Obrador B, Casas Rodrigo M, Sanchez Delgado J, Bella MR, Puig Domingo J. [Rapid progression of hepatocellular carcinoma after surgery: apropos of a case and review of the literature]. Gastroenterol Hepatol 2010;33:569-73. [PMID: 20627456 DOI: 10.1016/j.gastrohep.2010.03.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
94 Torres MC, Civetta E, D'amico C, Barbini L. Hepatitis B virus in Mar del Plata, Argentina: Genomic characterization and evolutionary analysis of subgenotype F1b. J Med Virol 2019;91:791-802. [PMID: 30570771 DOI: 10.1002/jmv.25383] [Reference Citation Analysis]
95 Hu Z, Zhou J, Wang H, Zhang M, Li S, Huang Y, Wu J, Li Z, Zhou L, Zheng S. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS One. 2013;8:e61620. [PMID: 23613886 DOI: 10.1371/journal.pone.0061620] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
96 Liu C, Chang L, Wang L. HBV DNA Test Among Blood Donations May Require Two Amplification Targets. Indian J Hematol Blood Transfus 2019;35:544-50. [PMID: 31388271 DOI: 10.1007/s12288-018-01064-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Al-Naamani K, Al-Maqbali A, Al-Sinani S. Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos Univ Med J 2013;13:380-5. [PMID: 23984022 DOI: 10.12816/0003259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
98 Lee O, Lee HO, Kim S, Kang YW, Lee MS, Han SJ, Shim MS, Yang NY. Differences in knowledge and attitudes toward hepatitis B infection and vaccination between adolescents in juvenile detention centers and in schools in South Korea. J Transcult Nurs 2010;21:65-72. [PMID: 19822884 DOI: 10.1177/1043659609348620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
99 Lu JJ, Chen EQ, Yang JH, Zhou TY, Liu L, Tang H. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients. Virol J. 2012;9:10. [PMID: 22233973 DOI: 10.1186/1743-422x-9-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
100 Body A, Hoy JF, Cheng AC, Giles ML. Incident hepatitis B infection subsequent to the diagnosis of HIV infection in a Melbourne cohort: missed opportunities for prevention. Sex Health 2014;11:5. [DOI: 10.1071/sh13019] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Yıldız O, Aygen B, Demirtürk N, Demirdal T, Inan D, Yıldırmak T, Kantürk A, Tütüncü E, Group HBS. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. World J Gastroenterol 2011; 17(45): 4987-4992 [PMID: 22174548 DOI: 10.3748/wjg.v17.i45.4987] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
102 Devesa M, Loureiro CL, Rivas Y, Monsalve F, Cardona N, Duarte MC, Poblete F, Gutierrez MF, Botto C, Pujol FH. Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol. 2008;80:20-26. [PMID: 18041024 DOI: 10.1002/jmv.21024] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 4.6] [Reference Citation Analysis]
103 Irshad M, Gupta P, Mankotia DS, Ansari MA. Multiplex qPCR for serodetection and serotyping of hepatitis viruses: A brief review. World J Gastroenterol 2016; 22(20): 4824-4834 [PMID: 27239109 DOI: 10.3748/wjg.v22.i20.4824] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
104 Kundi M. New hepatitis B vaccine formulated with an improved adjuvant system. Expert Review of Vaccines 2014;6:133-40. [DOI: 10.1586/14760584.6.2.133] [Cited by in Crossref: 128] [Cited by in F6Publishing: 115] [Article Influence: 16.0] [Reference Citation Analysis]
105 Zhu Q, Li N, Han Q, Li Z, Zhang G, Li F, Zhang P, Chen J, Lv Y, Liu Z. Single-nucleotide polymorphism at CYP27B1-1260, but not VDR Taq I, is possibly associated with persistent hepatitis B virus infection. Genet Test Mol Biomarkers 2012;16:1115-21. [PMID: 22963605 DOI: 10.1089/gtmb.2012.0148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
106 Huang J, Magnusson M, Törner A, Ye W, Duberg AS. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Br J Cancer. 2013;109:2917-2923. [PMID: 24178755 DOI: 10.1038/bjc.2013.689] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
107 Truong BX, Yano Y, Seo Y, Phuong TM, Tanaka Y, Kato H, Miki A, Utsumi T, Azuma T, Trach NK, Mizokami M, Hayashi Y, Kasuga M. Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol 2007;79:1293-304. [PMID: 17607788 DOI: 10.1002/jmv.20934] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
108 Jiang X, Zhang B, Zhao J, Xu Y, Han H, Su K, Tao J, Fan R, Zhao X, Li L, Li MD. Identification and characterization of SEC24D as a susceptibility gene for hepatitis B virus infection. Sci Rep 2019;9:13425. [PMID: 31530870 DOI: 10.1038/s41598-019-49777-8] [Reference Citation Analysis]
109 Liu Z, Ning H, Que S, Wang L, Qin X, Peng T. Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies. PLoS One 2014;9:e91410. [PMID: 24633141 DOI: 10.1371/journal.pone.0091410] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
110 Lafaro KJ, Demirjian AN, Pawlik TM. Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am. 2015;24:1-17. [PMID: 25444466 DOI: 10.1016/j.soc.2014.09.001] [Cited by in Crossref: 168] [Cited by in F6Publishing: 164] [Article Influence: 21.0] [Reference Citation Analysis]
111 Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet. 2009;126:685-696. [PMID: 19597844 DOI: 10.1007/s00439-009-0720-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
112 Qiu B, Wang X, Zhang P, Shi C, Zhang J, Qiu W, Wang W, Li D. Association of TNF-α promoter polymorphisms with the outcome of persistent HBV infection in a northeast Chinese Han population. Acta Biochim Biophys Sin (Shanghai). 2012;44:712-718. [PMID: 22695741 DOI: 10.1093/abbs/gms046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
113 Huang M, Chen H, Li C, Liu Y, Gan C, El-Sayed Ahmed MAE, Liu R, Shen C, Zhong R, Tian GB, Huang X, Xia J. Rapid Fulminant Progression and Mortality Secondary to Aeromonas dhakensis Septicemia with Hepatitis B Virus Infection Following the Ingestion of Snakehead Fish in Mainland China: A Case Report. Foodborne Pathog Dis 2020;17:743-9. [PMID: 32985901 DOI: 10.1089/fpd.2019.2780] [Reference Citation Analysis]
114 Li X, Liu B, Sun Y, Chen H, Chen H, Zhang H, Zhang Q, Ding Y. Single-dose pharmacokinetic properties, bioavailability, and tolerability of two lamivudine 100-mg tablet formulations: a randomized crossover study in healthy Chinese male subjects. Clin Ther 2013;35:1546-56. [PMID: 24011635 DOI: 10.1016/j.clinthera.2013.07.431] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
115 Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, Wang G, Lin D. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS One 2015;10:e0134568. [PMID: 26241657 DOI: 10.1371/journal.pone.0134568] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
116 Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res. 2010;40:31-48. [PMID: 20156298 DOI: 10.1111/j.1872-034x.2009.00597.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
117 Lee H, Kiang P, Watanabe P, Halon P, Shi L, Church DR. Hepatitis B virus infection and immunizations among Asian American college students: infection, exposure, and immunity rates. J Am Coll Health 2013;61:67-74. [PMID: 23409856 DOI: 10.1080/07448481.2012.753891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
118 Boppana SB, Britt WJ, Fowler K, Hutto SC, James SH, Kimberlin DW, Poole C, Ross SA, Whitley RJ. Pathogenesis of Non-Zika Congenital Viral Infections. J Infect Dis 2017;216:S912-8. [PMID: 29267912 DOI: 10.1093/infdis/jix431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
119 Samayoa B, Anderson MR, Alonso Pacheco KP, Lee C, Pittard A, Soltren A, Barrios Matos I, Arathoon E. Seroprevalence of HIV, hepatitis B, and syphilis among pregnant women at the general hospital, Guatemala City, 2005-2009. J Int Assoc Physicians AIDS Care (Chic). 2010;9:313-317. [PMID: 20841440 DOI: 10.1177/1545109710376669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
120 Amin-esmaeili M, Amin-esmaeili M, Rahimi-movaghar A, Rahimi-movaghar A, Razaghi E, Razaghi EM, Baghestani A, Baghestani AR, Jafari S, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon 2012;12:23-31. [DOI: 10.5812/hepatmon.4332] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
121 Gish RG, Cooper SL. Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic. J Viral Hepat 2011;18:e40-51. [PMID: 21143342 DOI: 10.1111/j.1365-2893.2010.01382.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
122 de Miranda NF, Georgiou K, Chen L, Wu C, Gao Z, Zaravinos A, Lisboa S, Enblad G, Teixeira MR, Zeng Y, Peng R, Pan-Hammarström Q. Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood 2014;124:2544-53. [PMID: 25171927 DOI: 10.1182/blood-2013-12-546309] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
123 Safer L, Ben Chaabene N, Melki W, Saffar H. [Epidemiology of viral hepatitis in Tunisia]. Rev Epidemiol Sante Publique 2006;54:377-80. [PMID: 17088701 DOI: 10.1016/s0398-7620(06)76732-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
124 Sherief LM, Ragab SM, Helwa MA, Kamal NM, Afify MR, Mohammed RTS, Mokhtar GAE, Sherbiny HS. CMV, B and C hepatitis among multi-transfused hereditary hemolytic Anemia children: an updated Egyptian experience. Ital J Pediatr 2021;47:117. [PMID: 34039385 DOI: 10.1186/s13052-021-01072-x] [Reference Citation Analysis]
125 Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011;21:401-416. [PMID: 22041528 DOI: 10.2188/jea.je20100190] [Cited by in Crossref: 183] [Cited by in F6Publishing: 128] [Article Influence: 16.6] [Reference Citation Analysis]
126 Custer B, Kessler D, Vahidnia F, Leparc G, Krysztof DE, Shaz B, Kamel H, Glynn S, Dodd RY, Stramer SL; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II). Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion 2015;55:1098-107. [PMID: 25470984 DOI: 10.1111/trf.12951] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
127 Lu QQ, Chen M, Wang XL, Cao SQ. Meta-analysis of diagnostic value of circulating microRNAs in hepatitis B-related fibrosis. Shijie Huaren Xiaohua Zazhi 2019; 27(22): 1365-1374 [DOI: 10.11569/wcjd.v27.i22.1365] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Jazwa A, Coleman MS, Gazmararian J, Wingate LT, Maskery B, Mitchell T, Weinberg M. Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential? Vaccine 2015;33:1393-9. [PMID: 25595868 DOI: 10.1016/j.vaccine.2015.01.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
129 Chao SD, Chang ET, Le PV, Prapong W, Kiernan M, So SKS. The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans. J Immigrant Minority Health 2009;11:281-90. [DOI: 10.1007/s10903-007-9094-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
130 Yang T, Wu MC. Discrimination against hepatitis B carriers in China. Lancet. 2011;378:1059. [PMID: 21924982 DOI: 10.1016/s0140-6736(11)61460-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
131 Zhu C, Song H, Xu F, Yi W, Liu F, Liu X. Hepatitis B virus inhibits the expression of complement C3 and C4, in vitro and in vivo. Oncol Lett 2018;15:7459-63. [PMID: 29731897 DOI: 10.3892/ol.2018.8223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
132 Zhang H, Li QY, Guo ZZ, Guan Y, Du J, Lu YY, Hu YY, Liu P, Huang S, Su SB. Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B. World J Gastroenterol 2012; 18(37): 5188-5196 [PMID: 23066312 DOI: 10.3748/wjg.v18.i37.5188] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
133 Ciccozzi M, Babakir-Mina M, Lo Presti A, Salpini R, Cella E, Gabanelli E, Teoharov P, Kevorkyan A, Perno CF, Zehender G. Molecular analysis of hepatitis B virus in Bulgaria. J Med Virol. 2013;85:49-54. [PMID: 23154875 DOI: 10.1002/jmv.23432] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
134 Li X, Li F, Zhang Y, Kang Y, Yu J, Yang F, Liu H, Qin Y, Huang Y, Mao R, Zhang J. Partial virological response to entecavir treatment in nucleos(t)ide-naïve patients with HBeAg-positive chronic hepatitis B is not caused by reduced sensitivity. Biochem Biophys Res Commun 2015;464:1185-91. [PMID: 26212437 DOI: 10.1016/j.bbrc.2015.07.101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
135 Liu M, Li L, Zheng SJ, Zhao J, Ungvari GS, Hall BJ, Duan ZP, Xiang YT. Prevalence of Major Depression and Its Associations With Demographic and Clinical Characteristics and Quality of Life in Chinese Patients With HBV-related Liver Diseases. Arch Psychiatr Nurs 2017;31:287-90. [PMID: 28499569 DOI: 10.1016/j.apnu.2017.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
136 Leung Y, Chan JI, Yoshida E, Wu HX, Daly PC. A cross-sectional analysis of acute hepatitis B virus reported to the Vancouver Coastal Health Authority from 2000 to 2003. Can J Gastroenterol 2006;20:471-4. [PMID: 16858499 DOI: 10.1155/2006/134268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
137 Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44. [DOI: 10.1002/ijc.21731] [Cited by in Crossref: 1822] [Cited by in F6Publishing: 1729] [Article Influence: 113.9] [Reference Citation Analysis]
138 Chang ET, Sue E, Zola J, So SK. 3 For Life: a model pilot program to prevent hepatitis B virus infection and liver cancer in Asian and Pacific Islander Americans. Am J Health Promot 2009;23:176-81. [PMID: 19149422 DOI: 10.4278/ajhp.071025115] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
139 Motta-Castro AR, Gomes SA, Yoshida CF, Miguel JC, Teles SA, Martins RM. Compliance with and response to hepatitis B vaccination in remaining quilombo communities in Central Brazil. Cad Saude Publica 2009;25:738-42. [PMID: 19347199 DOI: 10.1590/s0102-311x2009000400004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
140 Faria LC, Terrabuio DRB, Leblebicioglu H, Huprikar S. Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018;102:S66-71. [PMID: 29381580 DOI: 10.1097/TP.0000000000002013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Vedham V, Divi RL, Starks VL, Verma M. Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat 2014;13:177-94. [PMID: 23919392 DOI: 10.7785/tcrt.2012.500366] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
142 Afaghi P, Lapolla MA, Ghandi K. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients. Heliyon 2021;7:e06454. [PMID: 33748501 DOI: 10.1016/j.heliyon.2021.e06454] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
143 Xu X, Su Y, Song R, Sheng Y, Ai W, Wu X, Liu H. Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test. Hepatol Int. 2015;9:558-566. [PMID: 26187292 DOI: 10.1007/s12072-015-9643-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
144 Kim MJ, Lee H, Kiang P, Watanabe P, Torres MI, Halon P, Shi L, Church DR. Debunking the myth: low knowledge levels of HBV infection among Asian American college students. Asia Pac J Oncol Nurs 2015;2:8-16. [PMID: 27981087 DOI: 10.4103/2347-5625.152399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
145 Lim SG, Marcellin P, Tassopoulos N, Hadziyannis S, Chang TT, Tong M, Sievert W, Hu P, Arterburn S, Brosgart CL. Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B. Aliment Pharmacol Ther. 2007;26:1419-1428. [PMID: 17983369 DOI: 10.1111/j.1365-2036.2007.03506.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
146 Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz. 2006;101:149-155. [PMID: 16830707 DOI: 10.1590/s0074-02762006000200006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
147 Ma Y, Yu J, Chan HL, Chen YC, Wang H, Chen Y, Chan CY, Go MY, Tsai SN, Ngai SM. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol Cell Proteomics. 2009;8:2582-2594. [PMID: 19671925 DOI: 10.1074/mcp.m900180-mcp200] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
148 Chen F, He JL, Zheng M, Zhu HH, Li SP, Wang K, Zhang XX, Zhao YR, Wu SS, Chen Z. Complementary laboratory indices for predicting the disease status of patients with hepatitis B virus infection. J Viral Hepat 2013;20:566-74. [DOI: 10.1111/jvh.12067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
149 Zampino R, Boemio A, Sagnelli C, Alessio L, Adinolfi LE, Sagnelli E, Coppola N. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42): 11941-11953 [PMID: 26576083 DOI: 10.3748/wjg.v21.i42.11941] [Cited by in CrossRef: 107] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
150 Wang JY, Mao RC, Zhang YM, Zhang YJ, Liu HY, Qin YL, Lu MJ, Zhang JM. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat. 2015;22:128-136. [PMID: 25131617 DOI: 10.1111/jvh.12284] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
151 Li H, Fan MQ, Men TY, Wang YP, Xing TH, Fan JW, Peng ZH, Zhong L. Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone. Med Sci Monit 2016;22:332-40. [PMID: 26828767 DOI: 10.12659/MSM.895757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
152 Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect. 2011;62:165-171. [PMID: 21129400 DOI: 10.1016/j.jinf.2010.11.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
153 Romani S, Hosseini SM, Mohebbi SR, Kazemian S, Derakhshani S, Khanyaghma M, Azimzadeh P, Sharifian A, Zali MR. Interleukin-16 gene polymorphisms are considerable host genetic factors for patients’ susceptibility to chronic hepatitis B infection. Hepat Res Treat. 2014;2014:790753. [PMID: 25692036 DOI: 10.1155/2014/790753] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
154 Anagaw B, Shiferaw Y, Anagaw B, Belyhun Y, Erku W, Biadgelegn F, Moges B, Alemu A, Moges F, Mulu A. Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia. BMC Res Notes 2012;5:55. [PMID: 22264306 DOI: 10.1186/1756-0500-5-55] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
155 Liu X, Zhang L, Wu XP, Zhu XL, Pan LP, Li T, Yan BY, Xu AQ, Li H, Liu Y. Polymorphisms in IRG1 gene associated with immune responses to hepatitis B vaccination in a Chinese Han population and function to restrain the HBV life cycle. J Med Virol 2017;89:1215-23. [PMID: 28004399 DOI: 10.1002/jmv.24756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
156 Lin CY, Ding HJ, Lin T, Lin CC, Kuo TH, Kao CH. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET. Clin Imaging 2010;34:109-12. [PMID: 20189073 DOI: 10.1016/j.clinimag.2009.05.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
157 Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol. 2008;34:85-102. [PMID: 18270862 DOI: 10.1007/s12016-007-8013-6] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
158 Yang CH, Wu TS, Chiu CT. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy. Br J Dermatol. 2007;157:587-590. [PMID: 17596145 DOI: 10.1111/j.1365-2133.2007.08058.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
159 Nansseu JR, Mbogning DM, Monamele GC, Tamoh SF, Gonsu HK, Kouanfack C, Yanwou YN, Sando Z. Sero-epidemiology of human immunodeficiency virus, hepatitis B virus and hepatitis C virus: a cross-sectional survey in a rural setting of the West region of Cameroon. Pan Afr Med J 2017;28:201. [PMID: 29610639 DOI: 10.11604/pamj.2017.28.201.12717] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Veenstra DL, Spackman DE, Bisceglie A, Kowdley KV, Gish RG. Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis: EVALUATING ANTI-VIRAL THERAPY IN HBEAG-NEGATIVE CHB. Alimentary Pharmacology & Therapeutics 2008;27:1240-52. [DOI: 10.1111/j.1365-2036.2008.03691.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
161 Khanam A, Trehanpati N, Garg V, Kumar C, Garg H, Sharma BC, Sarin SK. Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure. Liver Int 2014;34:505-13. [PMID: 24754047 DOI: 10.1111/liv.12415] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
162 Krams IA, Skrinda I, Kecko S, Moore FR, Krama T, Kaasik A, Meija L, Lietuvietis V, Rantala MJ. Body height affects the strength of immune response in young men, but not young women. Sci Rep 2014;4:6223. [PMID: 25164474 DOI: 10.1038/srep06223] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
163 Mellen JS, Xia VW, Hashemzadeh M, Imagawa D, Jamal M, Hoefs J, Hu KQ. The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study. J Clin Gastroenterol 2010;44:364-70. [PMID: 19770675 DOI: 10.1097/MCG.0b013e3181b5c7a8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
164 Kibar F, Goruroglu Ozturk O, Ulu A, Erken E, Inal S, Dinkci S, Kurtaran B, Tasova Y, Aksu HS, Yaman A. Role of KIR genes and genotypes in susceptibility to or protection against hepatitis B virus infection in a Turkish cohort. Med Sci Monit. 2014;20:28-34. [PMID: 24407110 DOI: 10.12659/msm.889893] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
165 Shin-I T, Tanaka Y, Tateno Y, Mizokami M. Development and public release of a comprehensive hepatitis virus database. Hepatol Res. 2008;38:234-243. [PMID: 17877727 DOI: 10.1111/j.1872-034x.2007.00262.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
166 Han HX, Tang H. Application of adenoviral vector in biotherapy for hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2008; 16(15): 1649-1654 [DOI: 10.11569/wcjd.v16.i15.1649] [Reference Citation Analysis]
167 Slowik MK, Jhaveri R. Hepatitis B and C viruses in infants and young children. Semin Pediatr Infect Dis 2005;16:296-305. [PMID: 16210109 DOI: 10.1053/j.spid.2005.06.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
168 Bakhshipour A, Khalili M, Rafaiee R. Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient? Health Scope 2022;In Press. [DOI: 10.5812/jhealthscope.120505] [Reference Citation Analysis]
169 Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181. [PMID: 23597411 DOI: 10.1186/1471-2334-13-181] [Cited by in Crossref: 142] [Cited by in F6Publishing: 136] [Article Influence: 15.8] [Reference Citation Analysis]
170 Melhem NM, Rahhal N, Charide R, Kreidieh K, El-Khatib R. Human immunodeficiency virus and viral hepatitis among high-risk groups: Understanding the knowledge gap in the Middle East and North Africa Region. World J Hepatol 2015; 7(25): 2619-2630 [PMID: 26557955 DOI: 10.4254/wjh.v7.i25.2619] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
171 Hsu L, Bowlus CL, Stewart SL, Nguyen TT, Dang J, Chan B, Chen MS. Electronic messages increase hepatitis B screening in at-risk Asian American patients: a randomized, controlled trial. Dig Dis Sci. 2013;58:807-814. [PMID: 23073671 DOI: 10.1007/s10620-012-2396-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Iloeje UH, Yang HI, Chen CJ. Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver Int. 2012;32:1333-1341. [PMID: 22510145 DOI: 10.1111/j.1478-3231.2012.02805.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 8.4] [Reference Citation Analysis]
173 Kawabe N, Hashimoto S, Harata M, Nitta Y, Murao M, Nakano T, Shimazaki H, Arima Y, Komura N, Kobayashi K. The loss of HBeAg without precore mutation results in lower HBV DNA levels and ALT levels in chronic hepatitis B virus infection. J Gastroenterol. 2009;44:751-756. [PMID: 19430716 DOI: 10.1007/s00535-009-0061-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
174 Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193:225-231. [PMID: 21803030 DOI: 10.1016/j.cbi.2011.07.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 15.5] [Reference Citation Analysis]
175 Ismail SA, Cuadros DF, Benova L. Hepatitis B in Egypt: A cross-sectional analysis of prevalence and risk factors for active infection from a nationwide survey. Liver Int 2017;37:1814-22. [PMID: 28481452 DOI: 10.1111/liv.13469] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
176 Al-Busafi SA, Al-Harthi R, Al-Naamani K, Al-Zuhaibi H, Priest P. Risk Factors for Hepatitis B Virus Transmission 
in Oman. Oman Med J 2021;36:e287. [PMID: 34405055 DOI: 10.5001/omj.2021.99] [Reference Citation Analysis]
177 Amini-Bavil-Olyaee S, Maes P, Van Ranst M, Pourkarim MR. Providing strong evidence of nosocomial outbreak of hepatitis B virus infection. J Hosp Infect. 2012;80:269-270; author reply 270-272. [PMID: 22245118 DOI: 10.1016/j.jhin.2011.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
178 Chen CJ, Yang HI. Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol. 2011;26:628-638. [PMID: 21323729 DOI: 10.1111/j.1440-1746.2011.06695.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 168] [Article Influence: 15.6] [Reference Citation Analysis]
179 Podlaha O, Wu G, Downie B, Ramamurthy R, Gaggar A, Subramanian M, Ye Z, Jiang Z. Genomic modeling of hepatitis B virus integration frequency in the human genome. PLoS One 2019;14:e0220376. [PMID: 31356634 DOI: 10.1371/journal.pone.0220376] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
180 Turati F, Galeone C, Rota M, Pelucchi C, Negri E, Bagnardi V, Corrao G, Boffetta P, La Vecchia C. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2014;25:1526-1535. [PMID: 24631946 DOI: 10.1093/annonc/mdu020] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 11.4] [Reference Citation Analysis]
181 Asli AA, Moghadami M, Zamiri N, Tolide-Ei HR, Heydari ST, Alavian SM, Lankarani KB. Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy 2011;100:297-304. [PMID: 21269722 DOI: 10.1016/j.healthpol.2010.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
182 Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, Van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: Revised classification hurdles and updated resolutions. World J Gastroenterol 2014; 20(23): 7152-7168 [PMID: 24966586 DOI: 10.3748/wjg.v20.i23.7152] [Cited by in CrossRef: 102] [Cited by in F6Publishing: 96] [Article Influence: 12.8] [Reference Citation Analysis]
183 Shariff MI, Cox IJ, Gomaa AI, Khan SA, Gedroyc W, Taylor-robinson SD. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology 2014;3:353-67. [DOI: 10.1586/egh.09.35] [Cited by in Crossref: 197] [Cited by in F6Publishing: 194] [Article Influence: 24.6] [Reference Citation Analysis]
184 Zhou P, Yang F, Wang J, Mao R, Qi X, Huang Y, Zhang J. Improved Efficacy of a pegylated interferon-α-2a stepwise optimization treatment strategy in the treatment of hepatitis B e antigen-positive chronic hepatitis B patients. Medicine (Baltimore) 2015;94:e730. [PMID: 25929904 DOI: 10.1097/MD.0000000000000730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
185 Hennessey KA, Kim AA, Griffin V, Collins NT, Weinbaum CM, Sabin K. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health 2009;86:93-105. [PMID: 18622707 DOI: 10.1007/s11524-008-9305-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
186 Andrade AF, Oliveira-Silva M, Silva SG, Motta IJ, Bonvicino CR. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Mem Inst Oswaldo Cruz 2006;101:673-6. [PMID: 17072482 DOI: 10.1590/s0074-02762006000600016] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
187 Arora A, Sharma P, Tyagi P, Singla V, Arora V, Bansal N, Toshniwal J, Kumar A. Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India. J Clin Exp Hepatol 2013;3:288-95. [PMID: 25755516 DOI: 10.1016/j.jceh.2013.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
188 Wang CC, Tsai MC, Peng CM, Lee HL, Chen HY, Yang TW, Sung WW, Lin CC. Favorable liver cancer mortality-to-incidence ratios of countries with high health expenditure.Eur J Gastroenterol Hepatol. 2017;29:1397-1401. [PMID: 29023320 DOI: 10.1097/MEG.0000000000000969] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
189 Kostyushev DS, Zueva AP, Brezgin SA, Lipatnikov AD, Simirskii VN, Glebe D, Volchkova EV, Shipulin GA, Chulanov VP. [Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B]. Ter Arkh 2017;89:21-6. [PMID: 29260742 DOI: 10.17116/terarkh2017891121-26] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
190 Pan L, Zhang L, Zhang W, Wu X, Li Y, Yan B, Zhu X, Liu X, Yang C, Xu J. A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations. Hum Mol Genet. 2014;23:2210-2219. [PMID: 24282030 DOI: 10.1093/hmg/ddt586] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
191 Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, Dionne M, Embree J, McGeer A, Zickler P, Moltz KH, Martz R, Meyer I, McNeil S, Langley JM, Martins E, Heyward WL, Martin JT. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age. Vaccine 2012;30:2556-63. [PMID: 22326642 DOI: 10.1016/j.vaccine.2012.01.087] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
192 Tang R, Yang H, Gong Y, Liu Z, Li X, Wen T, Qu Z, Zhang S, Mei Q, Xu F. Improved Analytical Sensitivity of Lateral Flow Assay using Sponge for HBV Nucleic Acid Detection. Sci Rep 2017;7:1360. [PMID: 28465588 DOI: 10.1038/s41598-017-01558-x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
193 Xu D, Huang Y, Wang J. Gut microbiota modulate the immune effect against hepatitis B virus infection.Eur J Clin Microbiol Infect Dis. 2015;34:2139-2147. [PMID: 26272175 DOI: 10.1007/s10096-015-2464-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
194 Xu G, You Q, Pickerill S, Zhong H, Wang H, Shi J, Luo Y, You P, Kong H, Lu F, Hu L. Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine. J Med Virol 2010;82:1143-9. [DOI: 10.1002/jmv.21811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
195 Chuang SC, Lee YC, Wu GJ, Straif K, Hashibe M. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes Control 2015;26:1205-31. [PMID: 26134046 DOI: 10.1007/s10552-015-0615-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
196 Agarwal K, Fung SK, Nguyen TT, Cheng W, Sicard E, Ryder SD, Flaherty JF, Lawson E, Zhao S, Subramanian GM. Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection. J Hepatol. 2015;62:533-540. [PMID: 25450717 DOI: 10.1016/j.jhep.2014.10.035] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 12.6] [Reference Citation Analysis]
197 Yu XP, Guo RY, Su ML, Ming DS, Lin CZ, Deng Y, Lin ZZ, Su ZJ. Dynamic Changes of Treg and Th17 Cells and Related Cytokines Closely Correlate With the Virological and Biochemical Response in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogues Treatment. Hepat Mon. 2013;13:e15332. [PMID: 24403916 DOI: 10.5812/hepatmon.15332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
198 Mozzi A, Pontremoli C, Sironi M. Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches. Infect Genet Evol 2018;66:286-307. [PMID: 28951201 DOI: 10.1016/j.meegid.2017.09.028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
199 Sheikh MY, Atla PR, Ameer A, Sadiq H, Sadler PC. Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley. Gut Liver 2013;7:66-73. [PMID: 23423771 DOI: 10.5009/gnl.2013.7.1.66] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
200 Wang XP, Yao J, Guan J, Zhou ZQ, Zhang ZY, Yang J. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma. Biomed Pharmacother 2018;99:817-24. [PMID: 29710480 DOI: 10.1016/j.biopha.2018.01.131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
201 Niederau C. Chronic hepatitis B in 2014: Great therapeutic progress, large diagnostic deficit. World J Gastroenterol 2014; 20(33): 11595-11617 [PMID: 25206267 DOI: 10.3748/wjg.v20.i33.11595] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
202 Oh JK, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Ann Glob Health. 2014;80:384-392. [PMID: 25512154 DOI: 10.1016/j.aogh.2014.09.013] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 13.4] [Reference Citation Analysis]
203 Li D, Tang T, Patterson M, Ho M, Heathcote J, Shah H. The impact of hepatitis B knowledge and stigma on screening in Canadian Chinese persons. Can J Gastroenterol 2012;26:597-602. [PMID: 22993729 DOI: 10.1155/2012/705094] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 4.8] [Reference Citation Analysis]
204 Sánchez-tapias JM. Fármacos para el tratamiento de la hepatitis B crónica. Gastroenterología y Hepatología 2008;31:120-8. [DOI: 10.1157/13116500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Vu VD, Do A, Nguyen NH, Kim LH, Trinh HN, Nguyen HA, Nguyen KK, Nguyen M, Huynh A, Nguyen MH. Long-term follow-up and suboptimal treatment rates of treatment-eligible chronic hepatitis B patients in diverse practice settings: a gap in linkage to care. BMJ Open Gastroenterol 2015;2:e000060. [PMID: 26543565 DOI: 10.1136/bmjgast-2015-000060] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
206 Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010;14:1-21, vii. [PMID: 20123436 DOI: 10.1016/j.cld.2009.11.009] [Cited by in Crossref: 276] [Cited by in F6Publishing: 239] [Article Influence: 23.0] [Reference Citation Analysis]
207 Kue J, Thorburn S. Hepatitis B knowledge, screening, and vaccination among Hmong Americans. J Health Care Poor Underserved 2013;24:566-78. [PMID: 23728029 DOI: 10.1353/hpu.2013.0081] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
208 Pourkarim MR, Van Ranst M. Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon. 2011;11:783-785. [PMID: 22224075 DOI: 10.5812/kowsar.1735143x.773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
209 Stine JG, Caldwell SH. Hepatology highlights. Annals of Hepatology 2016;15:460-2. [DOI: 10.1016/s1665-2681(19)31694-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
210 Cheng A, Jose J, Larsen-Reindorf R, Small C, Nde H, Dugas L, Ehrhardt S, Nelson K, Ezeanolue E, Layden J. A Survey Study of Pregnant Women and Healthcare Practitioners Assessing the Knowledge of Attitudes and Practices of Hepatitis B Management at a Teaching Hospital in Kumasi, Ghana, West Africa. Open Forum Infect Dis 2015;2:ofv122. [PMID: 26566533 DOI: 10.1093/ofid/ofv122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
211 Zheng X, Ding W, Li G, Wu Y, Wu D, Zhu H, He J, Wang B, Zhao L, Zhu F, Lv H. Seroprevalence of transfusion-transmissible infectious agents among volunteer blood donors between 2006 and 2012 in Zhejiang, China. Blood Transfus 2015;13:401-10. [PMID: 26192780 DOI: 10.2450/2015.0271-14] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
212 Alvarado-Esquivel C, de la Ascensión Carrera-Gracia M, Conde-González CJ, Juárez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S, Torres-Valenzuela A, Sablon E. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico. J Antimicrob Chemother. 2006;57:221-223. [PMID: 16373428 DOI: 10.1093/jac/dki457] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
213 Zou Y, Chen T, Han M, Wang H, Yan W, Song G, Wu Z, Wang X, Zhu C, Luo X. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol. 2010;184:466-475. [PMID: 19949088 DOI: 10.4049/jimmunol.0900687] [Cited by in Crossref: 90] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
214 Practice Committee of American Society for Reproductive Medicine. Guidelines for reducing the risk of viral transmission during fertility treatment. Fertil Steril 2008;90:S156-62. [PMID: 19007616 DOI: 10.1016/j.fertnstert.2008.08.058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
215 Chen C, Iloeje UH, Yang H. Long-Term Outcomes in Hepatitis B: The REVEAL-HBV Study. Clinics in Liver Disease 2007;11:797-816. [DOI: 10.1016/j.cld.2007.08.005] [Cited by in Crossref: 131] [Cited by in F6Publishing: 119] [Article Influence: 8.7] [Reference Citation Analysis]
216 Chen JJ, Chang ET, Chen YR, Bailey MB, So SK. A model program for hepatitis B vaccination and education of schoolchildren in rural China. Int J Public Health 2012;57:581-8. [PMID: 21845405 DOI: 10.1007/s00038-011-0289-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
217 . Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Fertility and Sterility 2013;99:340-6. [DOI: 10.1016/j.fertnstert.2012.08.028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
218 Fitzgerald S, Chao J, Feferman Y, Perumalswami P, Sarpel U. Hepatitis B and Hepatocellular Carcinoma Screening Practices in Chinese and African Immigrant-Rich Neighborhoods in New York City. J Racial Ethn Health Disparities. 2016; Epub ahead of print. [PMID: 27797012 DOI: 10.1007/s40615-016-0296-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
219 Hu Y, Zhao Z, Wan Q. Facile preparation of carbon nanotube-conducting polymer network for sensitive electrochemical immunoassay of Hepatitis B surface antigen in serum. Bioelectrochemistry. 2011;81:59-64. [PMID: 21458390 DOI: 10.1016/j.bioelechem.2011.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
220 Gallego F, Pisano MB, Torres C, Caeiro L, Martínez Wassaf M, Balangero M, Campos R, Ré V. Molecular epidemiology of hepatitis B virus in Córdoba, Argentina. J Clin Virol 2014;61:204-10. [PMID: 25066884 DOI: 10.1016/j.jcv.2014.06.030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
221 Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW, Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study. J Hepatol. 2013;58:715-723. [PMID: 23201239 DOI: 10.1016/j.jhep.2012.11.025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
222 Liu W, Ma N, Gao X, Liu W, Jia J, Tang L, Li M, Yang L, Li T, Yan L, Zhang X, Yu F. Role of GSPT1 and GSPT2 polymorphisms in different outcomes upon Hepatitis B virus infection and prognosis to lamivudine therapy. Biosci Rep 2019;39:BSR20181668. [PMID: 30867251 DOI: 10.1042/BSR20181668] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Shim JH, Yu JS, Chung JJ, Kim JH, Kim KW. Segmental difference of the hepatic fibrosis from chronic viral hepatitis due to hepatitis B versus C virus infection: comparison using dual contrast material-enhanced MRI. Korean J Radiol 2011;12:431-8. [PMID: 21852903 DOI: 10.3348/kjr.2011.12.4.431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
224 Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V 3rd. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. J Hepatol 2014;61:210-8. [PMID: 24713185 DOI: 10.1016/j.jhep.2014.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
225 Ciccozzi M, Ciccaglione AR, Lo Presti A, Equestre M, Cella E, Ebranati E, Gabanelli E, Villano U, Bruni R, Yalcinkaya T, Tanzi E, Zehender G. Evolutionary dynamics of HBV-D1 genotype epidemic in Turkey: Hepatitis B Virus D1 Genotype. J Med Virol 2014;86:109-16. [DOI: 10.1002/jmv.23740] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
226 Chen H, Tu S, Teh CZ, Yip M, Choe JH, Hislop TG, Taylor VM, Thompson B. LAY BELIEFS ABOUT HEPATITIS AMONG NORTH AMERICAN CHINESE: IMPLICATIONS FOR HEPATITIS PREVENTION. J Community Health 2006;31:94-112. [DOI: 10.1007/s10900-005-9000-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
227 Chen CH, Lin CL, Kao CH. Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study. Medicine (Baltimore) 2015;94:e2276. [PMID: 26683953 DOI: 10.1097/MD.0000000000002276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
228 Du J, Xu Y, Wang J, Liu S, Liu Y, Zhang X, Xu E. 24 year outcomes of hepatitis B vaccination in Hangzhou, China. Hum Vaccin Immunother 2015;11:2051-60. [PMID: 25714188 DOI: 10.1080/21645515.2015.1008873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
229 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
230 Chen X, Shen Y, Xiang W. Distribution Characteristics of Hepatitis B Serological Markers in Hospitalized Children and Adolescents in Zhejiang, China between 2006 and 2010. Gut Liver 2011;5:210-6. [PMID: 21814603 DOI: 10.5009/gnl.2011.5.2.210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
231 Cakir M, Karakas T, Orhan F, Okten A, Gedik Y. Atopy in children with chronic hepatitis B virus infection. Acta Paediatr 2007;96:1343-6. [PMID: 17666105 DOI: 10.1111/j.1651-2227.2007.00405.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
232 Spackman DE, Veenstra DL. A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B. Pharmacoeconomics 2008;26:937-49. [PMID: 18850763 DOI: 10.2165/00019053-200826110-00006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
233 Sheikh MY, Atla PR, Raoufi R, Sadiq H, Sadler PC. Prevalence of hepatitis B infection among young and unsuspecting Hmong blood donors in the Central California Valley. J Community Health. 2012;37:181-185. [PMID: 21785858 DOI: 10.1007/s10900-011-9434-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
234 Dagnew M, Million Y, Destaw B, Adefris M, Moges F, Tiruneh M. Knowledge, Attitude, and Associated Factors Towards Vertical Transmission of Hepatitis B Virus Among Pregnant Women Attending Antenatal Care in Tertiary Hospitals in Amhara Region, Northwest Ethiopia: A Cross-Sectional Study. Int J Womens Health 2020;12:859-68. [PMID: 33116935 DOI: 10.2147/IJWH.S273560] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
235 Pathoumthong K, Khampanisong P, Quet F, Latthaphasavang V, Souvong V, Buisson Y. Vaccination status, knowledge and awareness towards hepatitis B among students of health professions in Vientiane, Lao PDR. Vaccine 2014;32:4993-9. [PMID: 25066734 DOI: 10.1016/j.vaccine.2014.07.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
236 Xu ZD, Xu HT, Yuan HB, Zhang H, Ji RH, Zou Z, Fu ZR, Shi XY. Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience. Hepatobiliary Pancreat Dis Int. 2012;11:34-39. [PMID: 22251468 DOI: 10.1016/s1499-3872(11)60123-9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
237 Robotin MC, George J. Community-based hepatitis B screening: what works? Hepatol Int 2014;8:478-92. [PMID: 25298848 DOI: 10.1007/s12072-014-9562-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
238 Yousfi N, Hattaf K, Tridane A. Modeling the adaptive immune response in HBV infection. J Math Biol. 2011;63:933-957. [PMID: 21234570 DOI: 10.1007/s00285-010-0397-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
239 D’Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma? World J Gastroenterol 2013; 19(14): 2141-2143 [PMID: 23599639 DOI: 10.3748/wjg.v19.i14.2141] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
240 Robotin MC. Hepatitis B prevention and control: Lessons from the East and the West. World J Hepatol 2011; 3(2): 31-37 [PMID: 21423912 DOI: 10.4254/wjh.v3.i2.31] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
241 Taylor VM, Teh C, Lam W, Acorda E, Li L, Coronado G, Yasui Y, Bajdik C, Hislop G. Evaluation of a hepatitis B educational ESL curriculum for Chinese immigrants. Can J Public Health 2009;100:463-6. [PMID: 20209742 [PMID: 20209742 DOI: 10.1007/bf03404345] [Cited by in Crossref: 16] [Article Influence: 1.3] [Reference Citation Analysis]
242 Ayers JW, Juon HS, Lee S, Park E. Hepatitis B vaccination prevalence and its predictors among Asian, Pacific Islander, Native American, and multiracial adults in the National Health and Nutrition Examination Survey. J Immigr Minor Health 2010;12:847-52. [PMID: 19967403 DOI: 10.1007/s10903-009-9309-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
243 Wei MT, Le AK, Chang MS, Hsu H, Nguyen P, Zhang JQ, Wong C, Wong C, Cheung R, Nguyen MH. Antiviral therapy and the development of osteopenia/osteoporosis among Asians with chronic hepatitis B. J Med Virol 2019;91:1288-94. [PMID: 30776311 DOI: 10.1002/jmv.25433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
244 Ezzikouri S, Kitab B, Rebbani K, Marchio A, Wain-Hobson S, Dejean A, Vartanian JP, Pineau P, Benjelloun S. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population. J Viral Hepat. 2013;20:678-686. [PMID: 24010642 DOI: 10.1111/jvh.12042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
245 Liu Y, Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118:818-824. [PMID: 20172840 DOI: 10.1289/ehp.0901388] [Cited by in Crossref: 559] [Cited by in F6Publishing: 439] [Article Influence: 46.6] [Reference Citation Analysis]
246 Wu J, Wang HL, Liu X, Ding C, Zhou Y, Fu X, Huang C, Zheng Y, Wang C, Li L, Yang S. Changing trends in viral hepatitis mortality in East and Southeast Asia between 1987 and 2015 and its prediction until 2030. Liver Int 2020;40:298-307. [PMID: 31674705 DOI: 10.1111/liv.14289] [Reference Citation Analysis]
247 Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org., Practice Committee of the American Society for Reproductive Medicine. Recommendations for reducing the risk of viral transmission during fertility treatment with the use of autologous gametes: a committee opinion. Fertil Steril 2020;114:1158-64. [PMID: 33280723 DOI: 10.1016/j.fertnstert.2020.09.133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
248 Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Magrini E, Zanini N, Cuppini A. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis. Pancreatology. 2013;13:147-160. [PMID: 23561973 DOI: 10.1016/j.pan.2013.01.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
249 Bhattacharya S, Gökdemir Ö, Bashar MA, Thiyagarajan A, Singh A. Is it the Right Time to Introduce the Hepatitis B Booster Vaccine in National Immunization Schedule? An Analysis from the Available Evidence. Indian J Community Med 2021;46:4-6. [PMID: 34035566 DOI: 10.4103/ijcm.IJCM_439_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
250 Ma Q, Cai J, Cai Y, Xu Y, Chang F, Xu L, Zhang G, Guo X. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e4970. [PMID: 27684844 DOI: 10.1097/MD.0000000000004970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Frew G, McGeorge E, Grant S, de Wildt G. Hepatitis B: A cross-sectional survey of knowledge, attitudes and practices amongst backpackers in Thailand. Travel Med Infect Dis 2017;15:57-62. [PMID: 27890663 DOI: 10.1016/j.tmaid.2016.11.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
252 Noubiap JJ, Joko WY, Nansseu JR, Tene UG, Siaka C. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis. 2013;17:e832-e837. [PMID: 23317526 DOI: 10.1016/j.ijid.2012.12.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 5.4] [Reference Citation Analysis]
253 Zhu C, Cao H, Zhou X, Dong C, Luo J, Zhang C, Liu J, Ling Y. Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis. Evid Based Complement Alternat Med 2013;2013:842824. [PMID: 24069058 DOI: 10.1155/2013/842824] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
254 Mi Y, Shi Q, Xu L, Shi R, Liu Y, Li P, Shen F, Lu W, Fan J. Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B. Dig Dis Sci 2015;60:243-51. [DOI: 10.1007/s10620-014-3341-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
255 Bernabe-Ortiz A, Carcamo CP, Scott JD, Hughes JP, Garcia PJ, Holmes KK. HBV infection in relation to consistent condom use: a population-based study in Peru. PLoS One 2011;6:e24721. [PMID: 21931828 DOI: 10.1371/journal.pone.0024721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
256 Tan YW. Antiviral treatment of hepatitis B virus and hepatitis C virus co-infection. Shijie Huaren Xiaohua Zazhi 2011; 19(15): 1614-1619 [DOI: 10.11569/wcjd.v19.i15.1614] [Reference Citation Analysis]
257 Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. PLoS One. 2013;8:e78548. [PMID: 24205255 DOI: 10.1371/journal.pone.0078548] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
258 Bini EJ, Perumalswami PV. Hepatitis B virus infection among American patients with chronic hepatitis C virus infection: prevalence, racial/ethnic differences, and viral interactions. Hepatology. 2010;51:759-766. [PMID: 20140950 DOI: 10.1002/hep.23461] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
259 Mankal PK, Abed J, Aristy JD, Munot K, Suneja U, Engelson ES, Kotler DP. Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population. Am J Drug Alcohol Abuse 2015;41:177-82. [PMID: 25320839 DOI: 10.3109/00952990.2014.964358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
260 Sheng Q, Ding Y, Li B, Han C, Li Y, Zhang C, Bai H, Wang J, Zhao L, Xia T, An Z, Zhang M, Dou X. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China. Int J Med Sci. 2018;15:796-801. [PMID: 30008589 DOI: 10.7150/ijms.25047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
261 Meng T, Shi X, Gong X, Deng H, Huang Y, Shan X, Shan Y, Huang A, Long Q. Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014). J Glob Antimicrob Resist 2017;8:74-81. [PMID: 28017671 DOI: 10.1016/j.jgar.2016.10.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
262 Abbas Z, Siddiqui AR. Management of hepatitis B in developing countries. World J Hepatol 2011; 3(12): 292-299 [PMID: 22216369 DOI: 10.4254/wjh.v3.i12.292] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
263 Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, Zhu L, Yang Y, Liu J, Chu M. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat Genet. 2013;45:1499-1503. [PMID: 24162738 DOI: 10.1038/ng.2809] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 10.4] [Reference Citation Analysis]
264 Hsu J, Liu D, Yu YM, Zhao HT, Chen ZR, Li J, Chen W. The Top Chinese Mobile Health Apps: A Systematic Investigation. J Med Internet Res 2016;18:e222. [PMID: 27573724 DOI: 10.2196/jmir.5955] [Cited by in Crossref: 49] [Cited by in F6Publishing: 30] [Article Influence: 8.2] [Reference Citation Analysis]
265 Nishida N, Sawai H, Kashiwase K, Minami M, Sugiyama M, Seto WK, Yuen MF, Posuwan N, Poovorawan Y, Ahn SH. New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia. PLoS One. 2014;9:e86449. [PMID: 24520320 DOI: 10.1371/journal.pone.0086449] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
266 Veenstra DL, Sullivan SD, Dusheiko GM, Jacobs M, Aledort JE, Lewis G, Patel KK. Cost-effectiveness of peginterferon α-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom: . European Journal of Gastroenterology & Hepatology 2007;19:631-8. [DOI: 10.1097/meg.0b013e3281108079] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
267 Liu C, Chen T, Lin J, Chen H, Chen J, Lin S, Yang B, Shang H, Ou Q. Evaluation of the performance of four methods for detection of hepatitis B surface antigen and their application for testing 116,455 specimens. J Virol Methods. 2014;196:174-178. [PMID: 24239632 DOI: 10.1016/j.jviromet.2013.10.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
268 Schnier C, Wallace L, Tempelton K, Aitken C, Gunson RN, Molyneaux P, McINTYRE P, Povey C, Goldberg D, Hutchinson S. Use of laboratory-based surveillance data to estimate the number of people chronically infected with hepatitis B living in Scotland. Epidemiol Infect 2014;142:2121-30. [PMID: 24480044 DOI: 10.1017/S0950268813003105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
269 Devesa M, Pujol FH. Hepatitis B virus genetic diversity in Latin America. Virus Res. 2007;127:177-184. [PMID: 17280734 DOI: 10.1016/j.virusres.2007.01.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
270 Wang C, Li YY, Li X, Wei LL, Yang XY, Xu DD, Jiang TT, Li ZJ, Chen ZL, Zhang X, Liu JY, Ping ZP, Li JC. Serum complement C4b, fibronectin, and prolidase are associated with the pathological changes of pulmonary tuberculosis. BMC Infect Dis 2014;14:52. [PMID: 24484408 DOI: 10.1186/1471-2334-14-52] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
271 Park JY, Heo J, Lee TJ, Yim HJ, Yeon JE, Lim YS, Seo MJ, Ahn SH, Lee MS. A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options. PLoS One 2013;8:e57900. [PMID: 23536775 DOI: 10.1371/journal.pone.0057900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
272 Bottero J, Lacombe K, Guéchot J, Serfaty L, Miailhes P, Bonnard P, Wendum D, Molina JM, Lascoux-Combe C, Girard PM. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50:1074-1083. [PMID: 19398234 DOI: 10.1016/j.jhep.2009.01.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
273 Bigoni J, Catarino R, Benski C, Viviano M, Munoz M, Tilahizandry H, Petignat P, Vassilakos P. High Burden of Human Papillomavirus Infection in Madagascar: Comparison With Other Sexually Transmitted Infections. Infect Dis (Auckl) 2018;11:1178633717752686. [PMID: 29434477 DOI: 10.1177/1178633717752686] [Reference Citation Analysis]
274 Chen X, Wang Y, Chen X, Cheng K, Li J, Lou J, Ke J, Yang Y, Gong Y, Zhu Y. Genetic variants in the regulatory region of SLC10A1 are not associated with the risk of hepatitis B virus infection and clearance. Infect Genet Evol. 2016;44:495-500. [PMID: 27491457 DOI: 10.1016/j.meegid.2016.07.043] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
275 Shan Y, Huang L, Xia Q. Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation. Sci Rep 2017;7:44652. [PMID: 28294176 DOI: 10.1038/srep44652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
276 Tang C, Chen Z, Peng G, Yang Z, Zhou L. Analysis of differential gene expression between chronic hepatitis B patients and asymptomatic hepatitis B carriers. J Gastroenterol Hepatol 2007;22:68-73. [DOI: 10.1111/j.1440-1746.2006.04371.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
277 La Torre G, Nicolotti N, de Waure C, Chiaradia G, Specchia ML, Mannocci A, Ricciardi W. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy. Virol J. 2008;5:84. [PMID: 18652653 DOI: 10.1186/1743-422X-5-84] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
278 Ragheb M, Elkady A, Tanaka Y, Murakami S, Attia FM, Hassan AA, Hassan MF, Shedid MM, Abdel Reheem HB, Khan A. Multiple intra-familial transmission patterns of hepatitis B virus genotype D in north-eastern Egypt. J Med Virol. 2012;84:587-595. [PMID: 22337297 DOI: 10.1002/jmv.23234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
279 Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 2011; 17(44): 4853-4857 [PMID: 22171125 DOI: 10.3748/wjg.v17.i44.4853] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
280 Li N, Fan XG, Chen ZH, Huang Y, Quan J, Liu ZB. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B. APMIS 2005;113:647-54. [PMID: 16309422 DOI: 10.1111/j.1600-0463.2005.apm_218.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
281 Li Q, Jia L, Hu W, Dong S, Cai C. Bioequivalence Evaluation of Two Formulations of Tenofovir Alafenamide Tablets in Healthy Subjects Under Fasting and Fed Conditions. Drug Des Devel Ther 2021;15:2551-62. [PMID: 34163141 DOI: 10.2147/DDDT.S304108] [Reference Citation Analysis]
282 Almasio PL, Craxì A. Management of hepatitis B virus infection in the underprivileged world. Liver Int. 2011;31:749-750. [PMID: 21645204 DOI: 10.1111/j.1478-3231.2011.02477.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
283 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
284 Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection: Predictive abilities of WFA + -M2BP in HBV. Hepatol Res 2017;47:226-33. [DOI: 10.1111/hepr.12712] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
285 Matsuura K, Isogawa M, Tanaka Y. Host genetic variants influencing the clinical course of hepatitis B virus infection. J Med Virol. 2016;88:371-379. [PMID: 26255971 DOI: 10.1002/jmv.24350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
286 Zehender G, Ebranati E, Gabanelli E, Shkjezi R, Lai A, Sorrentino C, Lo Presti A, Basho M, Bruno R, Tanzi E, Bino S, Ciccozzi M, Galli M. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS One. 2012;7:e37198. [PMID: 22662136 DOI: 10.1371/journal.pone.0037198] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
287 Luo Y, Xu Y, Li M, Xie Y, Gong G. A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2016;95:e4696. [PMID: 27559979 DOI: 10.1097/MD.0000000000004696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
288 Amaku M, Burattini MN, Coutinho FA, Lopez LF, Mesquita F, Naveira MC, Pereira GF, Santos MÉ, Massad E. Estimating the Size of the HCV Infection Prevalence: A Modeling Approach Using the Incidence of Cases Reported to an Official Notification System. Bull Math Biol 2016;78:970-90. [PMID: 27160282 DOI: 10.1007/s11538-016-0170-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
289 Oztas E, Kuzu UB, Zengin NI, Kalkan IH, Onder FO, Yildiz H, Celik HT, Akdogan M, Kilic MY, Koksal AS. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? Medicine (Baltimore). 2015;94:e1889. [PMID: 26632683 DOI: 10.1097/md.0000000000001889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
290 Yuan W, Lu HZ, Mei X, Zhang YY, Zhang ZG, Zou Y, Wang JF, Qian ZP, Guo HY. Cardiac health in patients with hepatitis B virus-related cirrhosis. Medicine (Baltimore) 2019;98:e14961. [PMID: 30921198 DOI: 10.1097/MD.0000000000014961] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
291 Levy AR, Kowdley KV, Iloeje U, Tafesse E, Mukherjee J, Gish R, Bzowej N, Briggs AH. The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons. Value in Health 2008;11:527-38. [DOI: 10.1111/j.1524-4733.2007.00297.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
292 Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012;12:636-48. [PMID: 22918466 DOI: 10.1038/nri3277] [Cited by in Crossref: 113] [Cited by in F6Publishing: 111] [Article Influence: 11.3] [Reference Citation Analysis]
293 Nguyen K, Pan C, Xia V, Hu J, Hu KQ. Clinical course of chronic hepatitis B (CHB) presented with normal ALT in Asian American patients. J Viral Hepat 2015;22:809-16. [PMID: 25611883 DOI: 10.1111/jvh.12388] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
294 Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E. Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatol Res 2018;48:275-85. [PMID: 29114991 DOI: 10.1111/hepr.12997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
295 Behzadi MA, Ziyaeyan M, Asaei S. Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran. Jundishapur J Microbiol 2014;7:e10127. [PMID: 25147713 DOI: 10.5812/jjm.10127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
296 Amin-Esmaeili M, Rahimi-Movaghar A, Razaghi EM, Baghestani AR, Jafari S. Factors Correlated With Hepatitis C and B Virus Infections Among Injecting Drug Users in Tehran, IR Iran. Hepat Mon 2012;12:23-31. [PMID: 22451840 DOI: 10.5812/kowsar.1735143X.806] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
297 Zehender G, Ebranati E, Gabanelli E, Sorrentino C, Lo Presti A, Tanzi E, Ciccozzi M, Galli M. Enigmatic origin of hepatitis B virus: An ancient travelling companion or a recent encounter? World J Gastroenterol 2014; 20(24): 7622-7634 [PMID: 24976700 DOI: 10.3748/wjg.v20.i24.7622] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
298 Mbanya DN, Tayou C. Blood safety begins with safe donations: update among blood donors in Yaounde, Cameroon. Transfus Med 2005;15:395-9. [DOI: 10.1111/j.1365-3148.2005.00608.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.4] [Reference Citation Analysis]
299 Han Y, Huang Z, Yang X, Liu H, Wu G. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. Journal of Ethnopharmacology 2008;118:148-53. [DOI: 10.1016/j.jep.2008.03.024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
300 Ojha R, Nandani R, Chatterjee N, Prajapati VK. Emerging Role of Circular RNAs as Potential Biomarkers for the Diagnosis of Human Diseases. Adv Exp Med Biol 2018;1087:141-57. [PMID: 30259364 DOI: 10.1007/978-981-13-1426-1_12] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
301 Song J, Zhang Z, Ji X, Su S, Liu X, Xu S, Han Y, Mu D, Liu H. Lack of evidence of hepatitis in patients with oral lichen planus in China: A case control study. Med Oral Patol Oral Cir Bucal 2016;21:e161-8. [PMID: 26827059 DOI: 10.4317/medoral.20812] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
302 Hassan MA, Kim WR, Li R, Smith CI, Fried MW, Sterling RK, Ghany MG, Wahed AS, Ganova-Raeva LM, Roberts LR, Lok ASF; Hepatitis B Research Network. Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B. Am J Epidemiol 2017;186:356-66. [PMID: 28525625 DOI: 10.1093/aje/kwx064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
303 Amesty S, Ompad DC, Galea S, Fuller CM, Wu Y, Koblin B, Vlahov D. Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City. J Community Health 2008;33:139-48. [DOI: 10.1007/s10900-007-9082-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
304 Li Z, Li LJ, Sun Y, Li J. Identification of natural compounds with anti-hepatitis B virus activity from Rheum palmatum L. ethanol extract. Chemotherapy. 2007;53:320-326. [PMID: 17785969 DOI: 10.1159/000107690] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
305 Abedi F, Madani H, Asadi A, Nejatizadeh A. Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran. Arch Virol 2011;156:629-35. [PMID: 21229276 DOI: 10.1007/s00705-010-0902-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
306 Djaogol T, Coste M, Marcellin F, Jaquet A, Chabrol F, Giles-Vernick T, Diallo A, Carrieri MP, Boyer S; ANRS 12356 AmBASS Study Group. Prevention and care of hepatitis B in the rural region of Fatick in Senegal: a healthcare workers' perspective using a mixed methods approach. BMC Health Serv Res 2019;19:627. [PMID: 31484515 DOI: 10.1186/s12913-019-4416-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
307 Brant LJ, Hurrelle M, Collins S, Klapper PE, Ramsay ME. Using automated extraction of hepatitis B tests for surveillance: evidence of decreasing incidence of acute hepatitis B in England. Epidemiol Infect 2012;140:1075-86. [DOI: 10.1017/s0950268811001683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
308 Liang J, Liu F, Wang F, Han T, Jing L, Ma Z, Gao Y. A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease. Biomed Res Int 2017;2017:8793278. [PMID: 28349067 DOI: 10.1155/2017/8793278] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
309 Boot HJ, Cremer J, Koedijk FD, van Ballegooijen WM, Op de Coul EL. Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences. J Med Virol 2008;80:233-41. [DOI: 10.1002/jmv.21080] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
310 Merrill RM, Hunter BD. Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis. 2011;15:e78-e121. [PMID: 21130675 DOI: 10.1016/j.ijid.2010.09.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
311 Ren H, Zhang TT, Hu WL. A -819 C/T polymorphism in the interleukin-10 promoter is associated with persistent HBV infection, but -1082 A/G and -592A/C polymorphisms are not: a meta-analysis. Arch Virol 2015;160:747-56. [PMID: 25583543 DOI: 10.1007/s00705-014-2317-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
312 Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St Gelais C, Panfil AR, Sun Y, Schlesinger LS, Anderson MZ, Green PL, López CB, Rosenberg BR, Wu L, Yount JS. Human Genetic Determinants of Viral Diseases. Annu Rev Genet 2017;51:241-63. [PMID: 28853921 DOI: 10.1146/annurev-genet-120116-023425] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
313 Nguyen VG, Wan K, Trinh HN, Li J, Zhang JQ, Nguyen MH. Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings. J Clin Gastroenterol 2015;49:145-9. [PMID: 25014233 DOI: 10.1097/MCG.0000000000000132] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
314 Pu X, Deng D, Chu C, Zhou T, Liu J. High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis. Sci Rep 2021;11:5081. [PMID: 33658585 DOI: 10.1038/s41598-021-84556-4] [Reference Citation Analysis]
315 Kumari S. Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study. Indian J Sex Transm Dis AIDS 2020;41:22-9. [PMID: 33062977 DOI: 10.4103/0253-7184.196887] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
316 Kwak HD, Kim SH, Seo YS, Song KJ. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Occup Environ Med. 2016;73:857-863. [PMID: 27484956 DOI: 10.1136/oemed-2016-103724] [Cited by in Crossref: 35] [Cited by in F6Publishing: 103] [Article Influence: 5.8] [Reference Citation Analysis]
317 Cheng X, Wang Y, Tian J, Zhou L, Chen X, Guo H, Zeng J, Shen N, Li J, Ke J, Zhu Y, Gong J, Chang J, Liu L, Zhong R. SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake. J Viral Hepat 2019;26:1178-85. [PMID: 31177598 DOI: 10.1111/jvh.13157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
318 Turnour CE, Cretikos MA, Conaty SJ. Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data. Australian and New Zealand Journal of Public Health 2011;35:22-6. [DOI: 10.1111/j.1753-6405.2010.00657.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
319 Chen HF, Xu BX, Shen HS, Li ZY, Jin LJ, Tang JQ, Wang J, Zhu JJ, Qin LM, Cui QY, Ren YY, Wu TQ. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia. Drug Des Devel Ther 2014;8:1299-305. [PMID: 25246771 DOI: 10.2147/DDDT.S67908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
320 Xu XY, Kong H, Song RX, Zhai YH, Wu XF, Ai WS, Liu HB. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One. 2014;9:e100182. [PMID: 24964038 DOI: 10.1371/journal.pone.0100182] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
321 Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol 2005;5:26. [PMID: 16086833 DOI: 10.1186/1471-230X-5-26] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
322 Taylor VM, Gregory Hislop T, Bajdik C, Teh C, Lam W, Acorda E, Li L, Yasui Y. Hepatitis B ESL education for Asian immigrants. J Community Health 2011;36:35-41. [PMID: 20559696 DOI: 10.1007/s10900-010-9279-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
323 White B, Dore GJ, Lloyd A, Rawlinson W, Maher L. Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney. Australian and New Zealand Journal of Public Health 2012;36:351-6. [DOI: 10.1111/j.1753-6405.2012.00881.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
324 Pande C, Sarin SK, Patra S, Bhutia K, Mishra SK, Pahuja S, Jain M, Srivastava S, Dar SB, Trivedi SS, Mukhopadhyay CK, Kumar A. Prevalence, risk factors and virological profile of chronic hepatitis B virus infection in pregnant women in India. J Med Virol 2011;83:962-7. [PMID: 21503907 DOI: 10.1002/jmv.22017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
325 Chen Jr MS, Dang J. Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control. World J Gastroenterol 2015; 21(42): 11924-11930 [PMID: 26576081 DOI: 10.3748/wjg.v21.i42.11924] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
326 Fan L, Liu J, Habibov NN. A Multilevel Logit Estimation on the Determinants of Utilization of Preventive Health Care and Healthy Lifestyle Practice in China. World Med Health Policy 2015;7:309-28. [PMID: 26688776 DOI: 10.1002/wmh3.160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
327 Onder B, Ozer NB, Onder FO, Selcuk B, Kurtaran A, Yalcin E, Akyüz M. Incidence of acute hepatitis B in patients with spinal cord injury. Spinal Cord 2011;49:1155-7. [PMID: 21808259 DOI: 10.1038/sc.2011.80] [Reference Citation Analysis]
328 Li HJ, Zhai NC, Song HX, Yang Y, Cui A, Li TY, Tu ZK. The Role of Immune Cells in Chronic HBV Infection. J Clin Transl Hepatol. 2015;3:277-283. [PMID: 26807384 DOI: 10.14218/jcth.2015.00026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
329 Zhang H, Guan Y, Lu YY, Hu YY, Huang S, Su SB. Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B. Evid Based Complement Alternat Med 2013;2013:751341. [PMID: 23554832 DOI: 10.1155/2013/751341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
330 Tsai NC, Holck PS, Wong LL, Ricalde AA. Seroepidemiology of hepatitis B virus infection: analysis of mass screening in Hawaii. Hepatol Int 2008;2:478-85. [PMID: 19669323 DOI: 10.1007/s12072-008-9103-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
331 Cao B, Liu X, Hou F, Li W, Han Z, Zhang Q, Dai Y, Xu C, Qi H. The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver Int 2009;29:1383-8. [PMID: 19744071 DOI: 10.1111/j.1478-3231.2009.02053.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
332 Liu F, Duan X, Wan Z, Zang H, You S, Yang R, Liu H, Li D, Li J, Zhang Y, Xin S. Lower number and decreased function of natural killer cells in hepatitis B virus related acute-on-chronic liver failure. Clinics and Research in Hepatology and Gastroenterology 2016;40:605-13. [DOI: 10.1016/j.clinre.2016.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
333 Kretzschmar M, Mangen M, van de Laar M, de Wit A. Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine 2009;27:1254-60. [DOI: 10.1016/j.vaccine.2008.12.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
334 Duffell EF, van de Laar MJ. Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009. Euro Surveill 2015;20:17-24. [PMID: 25860392 DOI: 10.2807/1560-7917.es2015.20.13.21080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
335 Wu B, Li T, Chen H, Shen J. Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis. Value Health. 2010;13:592-600. [PMID: 20561341 DOI: 10.1111/j.1524-4733.2010.00733.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
336 Hutton DW, Brandeau ML, So SK. Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces (Providence). 2011;41:289-300. [PMID: 21760650 DOI: 10.1287/inte.1100.0511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
337 You S, Rong Y, Zhu B, Zhang A, Zang H, Liu H, Li D, Wan Z, Xin S. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int. 2013;7:714-720. [PMID: 26201805 DOI: 10.1007/s12072-013-9424-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
338 Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One. 2012;7:e44611. [PMID: 22957088 DOI: 10.1371/journal.pone.0044611] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 8.4] [Reference Citation Analysis]
339 Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, Gerber L, Younossi ZM. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;26:815-820. [PMID: 17767465 DOI: 10.1111/j.1478-3231.2007.01558.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
340 Yuan Y, Iloeje U, Li H, Hay J, Yao GB. Economic Implications of Entecavir Treatment in Suppressing Viral Replication in Chronic Hepatitis B (CHB) Patients in China from a Perspective of the Chinese Social Security Program. Value in Health 2008;11:S11-22. [DOI: 10.1111/j.1524-4733.2008.00362.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
341 Veenstra DL, Sullivan SD, Clarke L, Iloeje UH, Tafesse E, Di Bisceglie A, Kowdley KV, Gish RG. Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B: . PharmacoEconomics 2007;25:963-77. [DOI: 10.2165/00019053-200725110-00006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
342 Keystone JS. Travel-related hepatitis B: risk factors and prevention using an accelerated vaccination schedule. Am J Med 2005;118 Suppl 10A:63S-8S. [PMID: 16271544 DOI: 10.1016/j.amjmed.2005.07.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
343 Abara WE, Cha S, Malik T, DeSimone MS, Schillie S, Collier M, Schumann B, Klemme M, Kamb M. Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014. J Pediatric Infect Dis Soc 2018;7:290-5. [PMID: 28992071 DOI: 10.1093/jpids/pix062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
344 Huo T, Cao J, Tian Y, Shi X, Wu L, Zhang M, Wong LL, Zhao L. Effect of Concomitant Positive Hepatitis B Surface Antigen on the Risk of Liver Metastasis: A Retrospective Clinical Study of 4033 Consecutive Cases of Newly Diagnosed Colorectal Cancer. Clin Infect Dis 2018;66:1948-52. [PMID: 29293940 DOI: 10.1093/cid/cix1118] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
345 Dagnew M, Million Y, Gizachew M, Eshetie S, Yitayew G, Asrade L, Adefris M, Moges F, Tiruneh M. Hepatitis B and C Viruses' Infection and Associated Factors among Pregnant Women Attending Antenatal Care in Hospitals in the Amhara National Regional State, Ethiopia. Int J Microbiol 2020;2020:8848561. [PMID: 33133191 DOI: 10.1155/2020/8848561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Pournik O, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S. Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: a data-mining approach. Hepat Mon 2013;13:e7652. [PMID: 23922559 DOI: 10.5812/hepatmon.7652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
347 Woo G, Tomlinson G, Yim C, Lilly L, Therapondos G, Wong DK, Ungar WJ, Einarson TR, Sherman M, Heathcote JE, Krahn M. Health state utilities and quality of life in patients with hepatitis B. Can J Gastroenterol 2012;26:445-51. [PMID: 22803020 DOI: 10.1155/2012/736452] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
348 Bonvicino CR, Moreira MA, Soares MA. Hepatitis B virus lineages in mammalian hosts: Potential for bidirectional cross-species transmission. World J Gastroenterol 2014; 20(24): 7665-7674 [PMID: 24976704 DOI: 10.3748/wjg.v20.i24.7665] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
349 Nguyen ATL, Le XTT, Do TTT, Nguyen CT, Hoang Nguyen L, Tran BX, Le HT. Knowledge, Preference, and Willingness to Pay for Hepatitis B Vaccination Services among Woman of Reproductive Age in Vietnam. Biomed Res Int 2019;2019:9154918. [PMID: 30915364 DOI: 10.1155/2019/9154918] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
350 Miller DS, Halpern M, Kotlarski I, Jilbert AR. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Virology 2006;348:297-308. [PMID: 16469347 DOI: 10.1016/j.virol.2005.12.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
351 Luuse A, Dassah S, Lokpo S, Ameke L, Noagbe M, Adatara P, Hagan O, Binka F. Sero-Prevalence of Hepatitis B Surface Antigen Amongst Pregnant Women Attending an Antenatal Clinic, Volta Region, Ghana. J Public Health Afr 2016;7:584. [PMID: 28299162 DOI: 10.4081/jphia.2016.584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
352 Robotin M, Patton Y, George J. Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. Int J Gen Med. 2013;6:115-122. [PMID: 23662074 DOI: 10.2147/ijgm.s41299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
353 Zhang X, Jia J, Dong J, Yu F, Ma N, Li M, Liu X, Liu W, Li T, Liu D. HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy. J Viral Hepat. 2014;21:491-498. [PMID: 24750255 DOI: 10.1111/jvh.12159] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
354 Ni HM, Williams JA, Yang H, Shi YH, Fan J, Ding WX. Targeting autophagy for the treatment of liver diseases. Pharmacol Res 2012;66:463-74. [PMID: 22871337 DOI: 10.1016/j.phrs.2012.07.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
355 Kallman JB, Arsalla A, Park V, Dhungel S, Bhatia P, Haddad D, Wheeler A, Younossi ZM. Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians. Aliment Pharmacol Ther. 2009;29:1019-1024. [PMID: 19220207 DOI: 10.1111/j.1365-2036.2009.03961.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 32] [Article Influence: 7.2] [Reference Citation Analysis]
356 Bini EJ, Kritz S, Brown LS, Robinson J, Calsyn D, Alderson D, Tracy K, McAuliffe P, Smith C, Rotrosen J. Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States. J Subst Abuse Treat. 2012;42:438-445. [PMID: 22035702 DOI: 10.1016/j.jsat.2011.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
357 Gunardi H, Iskandar MY, Turyadi, Ie SI, Dwipoerwantoro PG, Gani RA, Muljono DH. Hepatitis B virus infection in children of HBV-related chronic liver disease patients: a study of intra-familial HBV transmission. Hepatol Int 2017;11:96-104. [PMID: 27624502 DOI: 10.1007/s12072-016-9764-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
358 Kolou M, Katawa G, Salou M, Gozo-Akakpo KS, Dossim S, Kwarteng A, Prince-David M. High Prevalence of Hepatitis B Virus Infection in the Age Range of 20-39 Years Old Individuals in Lome. Open Virol J 2017;11:1-7. [PMID: 28217218 DOI: 10.2174/1874357901710011001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
359 Fan W, Shi B, Wei H, Du G, Song S. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B. Virus Genes. 2011;42:162-170. [PMID: 21161360 DOI: 10.1007/s11262-010-0557-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
360 Chao J, Chang ET, So SK. Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC Public Health. 2010;10:98. [PMID: 20184740 DOI: 10.1186/1471-2458-10-98] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
361 Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol 2015; 7(26): 2648-2663 [PMID: 26609342 DOI: 10.4254/wjh.v7.i26.2648] [Cited by in Crossref: 116] [Cited by in F6Publishing: 112] [Article Influence: 16.6] [Reference Citation Analysis]
362 Takahashi LM, Kim AJ, Sablan-Santos L, Quitugua LF, Aromin J, Lepule J, Maguadog T, Perez R, Young L, Young S. Hepatitis B among Pacific Islanders in Southern California: how is health information associated with screening and vaccination? J Community Health 2011;36:47-55. [PMID: 20556491 DOI: 10.1007/s10900-010-9285-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
363 Chen SC, Toy M, Yeh JM, Wang JD, Resch S. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment. Pediatrics. 2013;131:e1135-e1143. [PMID: 23530168 DOI: 10.1542/peds.2012-1262] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
364 Jin X, Chen YP, Yang YD, Li YM, Zheng L, Xu CQ. Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B. PLoS One. 2012;7:e34198. [PMID: 22479562 DOI: 10.1371/journal.pone.0034198] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
365 Asselah T, Lada O, Moucari R, Marcellin P. Clevudine: a promising therapy for the treatment of chronic hepatitis B. Expert Opinion on Investigational Drugs 2008;17:1963-74. [DOI: 10.1517/13543780802535760] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
366 Cama E, Brener L, Broady T, Hopwood M, Treloar C. Australian health and medical workers' concerns around providing care to people living with hepatitis B. Health Soc Care Community 2021. [PMID: 33825261 DOI: 10.1111/hsc.13368] [Reference Citation Analysis]